Use of Wegovy and other weight-loss drugs soars among kids and young adults Read full article: Use of Wegovy and other weight-loss drugs soars among kids and young adults Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and young adults.
As I was writing this article (Feb 27, ~5:45 AM EST), I reached out to him for clarification either to provide an updated or corrected comment, or to point me toward data I may be overlooking (which is entirely possible)
Avoiding these gives you a significant advantage
Injectable GLP-1s may be more suitable for: Patients aiming for the maximum possible reduction in body weight, those with co-existing conditions like heart disease or chronic kidney disease (due to specific FDA approvals for Ozempic), or those who prefer a simple weekly medication schedule
Temperatures in a parked car reach extremes in both summer and winter that can compromise the plastic barrel, the rubber plunger tip, and the needle coating
